Delivery Order SPE2DB20D2104-SPE2DB23FT04Y

Award Date 4/12/23
Potential Completion Date 4/13/23
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,990.44 firm-fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the delivery of 90 capsules of Orlistat 120 mg. The award has an ultimate completion date of May 15, 2023. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, as well as a separate $750,000 IDC with the Department of Justice Federal Bureau of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,009.95 and is for the provision of Orlistat 120 mg capsules. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award is for the delivery of ORLISTAT 120 MG CAPSULE 90S pharmaceutical products to the Defense Logistics Agency (DLA). The $2,974.61 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, which is a subsidiary of the parent company Cencora, Inc. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,017.31 delivery order is for ORLISTAT 120 MG CAPSULE 90S, a prescription medication. The contract has a firm fixed price and runs through May 2, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award, valued at $7,106.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4560715315 ORLISTAT 120 MG CAPSULE 90S, a pharmaceutical product. This award is not associated with a set-aside requirement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $1,214 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 90 capsules of Xenical, a weight loss medication, to an agency location in Conshohocken, Pennsylvania. Performance is required from August 17 to August 18, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation. The Defense Logistics Agency will...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,920.91 Firm Fixed Price Delivery Order contract is for the supply of ORSERDU 345 MG TABLET 30S, a pharmaceutical product, with a period of performance through February 5, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of ORSERDU 345 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $26,927.56 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,920.91 firm fixed-price delivery order contract is for the supply of ORSERDU 345 MG TABLET 30S, which are likely pharmaceutical products. The contract has an ultimate completion date of January 24, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,651.12 firm fixed-price delivery order is for the drug Orilissa 150 mg tablet, with a completion date of May 2, 2024. The contract is not set aside for any specific business type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FT04Y
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,990.44 firm-fixed-price delivery order is for the supply of Orlistat 120 mg capsules. The contract has an ultimate completion date of April 13, 2023 and was awarded on April 12, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 2/27/25, 1:27 PM